---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-079679"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2024-07-15T23:59:59+00:00"
generated_at: "2026-05-31T20:38:59.398096+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Rockwell Medical amends asset purchase deal with Evoqua; affirms 2024 gross margin guidance of 14-16%

## Summary
- Amendment reduces First Deferred Payment by $322,260 to $2,177,740, payable in four quarterly installments through April 2025.
- Second Deferred Payment of $2.5M payable in four quarterly installments from July 2025 to April 2026.
- CEO reaffirmed 2024 non-GAAP gross margin guidance of 14-16% at HC Wainwright conference, correcting a prior misstatement of 13-15% that referred to gross profit dollars.
- Amendment clarifies undeliverable equipment is excluded from acquired assets and includes a release of claims related to expired inventory disposal.

## SEC filing metadata
- accession: 0001104659-24-079679
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2024-07-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000110465924079679/0001104659-24-079679-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000110465924079679/tm2419450d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-079679
- JSON: https://secwatch.observer/filing/0001104659-24-079679.json
- Plain text: https://secwatch.observer/filing/0001104659-24-079679.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.